(Q40470276)

20 September 2017

1 reference

title

Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. (English)

1 reference

20 September 2017

1 reference

1 reference

2

Tefferi A

1 reference

20 September 2017

Moder KG

1

1 reference

20 September 2017

Cohen MD

series ordinal

3

1 reference

20 September 2017

Menke DM

series ordinal

4

1 reference

20 September 2017

Luthra HS

series ordinal

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

American Journal of Medicine

20 September 2017

published in

1 reference

20 September 2017

volume

99

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

276-281

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

20 September 2017

1 reference

AN ASSOCIATION BETWEEN THE RHEUMATIC DISEASES AND THE RETICULOSES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Cancer morbidity in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Incidence of Cancer Among Patients With Rheumatoid Arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Neoplasms of the immune system in rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Non-Hodgkin's lymphoma in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Neoplastic lymphoproliferation in autoimmune disease: an updated review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Review of United States data on neoplasms in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Leukemia, lymphoma, and multiple myeloma following selected medical conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

A patient with rheumatoid arthritis and lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Cytogenetic effects of methotrexate on human cells in vivo: comparison between results obtained by chromosome studies on bone-marrow cells and blood lymphocytes and by the micronucleus test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

Carcinogenicity of antineoplastic agents in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980160-0

10.1016/S0002-9343(99)80160-0

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference